Hired and Retired: Big pharma to biotech trend continues
As the stream of executives flowing from large pharma companies to smaller biotechs builds into torrent, another month has passed with a number of significant switches. Notably, two former Genentech employees, responsible for work on some of its bestselling products, have made the move to become executives at a very early stage biotech that has only just completed a Series B financing.
In addition, Jacquelyn (“Jackie”) Fouse, a name with a strong reputation in the biotech industry, has secured a CEO position at a fast-growing biotech company, which has already seen two drug launches in recent years.
